Prof. R. Purwar – India’s first CAR-T cell therapy
Cell and gene therapy, NexCAR19, developed by Prof. Rahul Purwar and his group has now received approval from CDSCO (Central Drugs Standard Control Organization), Govt of India, for the treatment of r/r B-cell lymphomas and leukemia.
News Article links:
- https://www.thehindu.com/business/cdsco-approves-immunoacts-car-t-cell-therapy/article67418047.ece
- https://www.hindustantimes.com/cities/mumbai-news/indias-first-cell-therapy-for-cancer-treatment-receives-regulatory-approval-101697224829344.html
- https://www.moneycontrol.com/news/trends/health/immunoact-gets-cdsco-approval-for-indias-first-car-t-cell-therapy-for-blood-cancer-11531821.html
- https://timesofindia.indiatimes.com/home/science/indias-1st-car-t-cell-therapy-developed-by-immunoact-gets-cdsco-nod/articleshow/104403237.cms?from=mdr